. Author manuscript; available in PMC: 2010 Sep 1.

Published in final edited form as: Toxicol Appl Pharmacol. 2009 Jun 16;239(2):200–207. doi: 10.1016/j.taap.2009.06.007

Table 8.

Stratified analyses of the AS3MT gene haplotypes for the A-477G, Met287Thr and T35587C SNPs and the risk of arsenic-skin lesions.

Haplotype	Non-lesion No. (%)	As-skin lesion No. (%)	Adjusted OR^a	95% CI	P
1(ATT)	42 (84)	58 (84)
2 (GTT)	29 (58)	43 (62)	1.61	0.6–4.3	0.34
3 (ACT)	3 (6)	6 (9)	4.56	0.8–26.4	0.09
4 (ATC)	14 (28)	20 (29)	0.65	0.2–1.9	0.43
6 (GCT)	4 (8)	9 (13)	3.01	0.6–13.9	0.16
7 (GCC)	1 (2)	4 (6)	2.02	0.2–22.7	0.56

Logistic regression analyses adjusted by age, gender and TWE.